We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086) today announced the successful completion of a short-form merger of Home Diagnostics, Inc...
Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086) and Home Diagnostics, Inc. (NASDAQ: HDIX) today announced the successful completion of the...
FT. LAUDERDALE, Fla. and LEWISVILLE, Texas, March 3 /PRNewswire/ -- Home Diagnostics, Inc. , a leading manufacturer and marketer of diabetes testing supplies, selected Parago, an innovative...
Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty and violations of state law in connection with the proposed sale of Home Diagnostics...
Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), through its wholly-owned subsidiary Nippon Product Acquisition Corporation (the “Purchaser”...
MIAMI, FL -- (Marketwire) -- 02/04/10 -- Stock Market Alerts' performance stock list includes: Frederick's of Hollywood Group Inc. (AMEX: FOH), Citi (NYSE: C), Motorola, Inc. (NYSE: MOT) and Home...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Home Diagnostics, Inc. (“Home Diagnostics” or the “Company”...
Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of Home...
Levi & Korsinsky is investigating the Board of Directors of Home Diagnostics, Inc. (“Home Diagnostics” or the “Company”) (NasdaqGS: HDIX) for possible breaches of fiduciary duty...
Home Diagnostics, Inc. (NASDAQ: HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions